Cuba will have its vaccine against Covid-19 in January
Cuba will have its vaccine against Covid-19 next January, the results of which should be available on February 11 and will be made public on February 15, according to information released by the Cuban Public Registry of Clinical Trials.
According to the announcement, the drug, which has raised great hopes in terms of achieving control of this dangerous virus, will be called Sovereign 01 and the research includes tests on 676 people between 19 and 80 years old.
Cuban scientists of the Finlay Institute are responsible for the development of the new drug, whose study will be randomized, controlled, adapted and multicentered, with the purpose of evaluating the safety, reactogenicity and immunogenicity of the candidate in a two-dose scheme.
The registration of this project was carried out on August 13, when the Center for the State Control of Medicines, Equipment and Medical Devices (CECMEC) approved submitting the vaccine candidate to Phase I / II clinical trials.
Precisely, last Monday Cuban president, Miguel Díaz-Canel, verified the progress of the Cuban project and expressed confidence in the response of the island's science to prevent the spread of the SARS-CoV-2 coronavirus.
The Finlay Institute is a scientific organization dedicated to the research and production of human vaccines and is considered one of the most prestigious and internationally recognized centers in its field.
In its almost three decades of foundation, it has developed and produced numerous vaccines, including VA-MENGOC-BC, anti-meningococcal BC., against leptospirosis, anti-tetanus, and anti-diphtheria-tetanus.